DVLP Medicines
Patrick Perry has a strong work experience in the financial industry. In 2023, they serve as the Chief Financial Officer and General Manager at DVLP Medicines, as well as a Principal at Artesia Advisors LLC. Prior to these roles, they worked at Valo as the Head of Capital Markets and Investor Relations, where they played a key role in raising approximately $500M from institutional investors. From 2018 to 2019, Patrick served as the Head of Business Development at Tremblant Capital, a global asset management firm. Before that, they held the position of Head of Business Development at Geode Capital Management from 2008 to 2017, where they led client-facing teams and identified business opportunities. Patrick also gained experience at BlackRock, JonesTrading, and Allen & Company, focusing on alternative strategies, event-driven strategies, and institutional sales. Overall, Patrick's work experience demonstrates a diverse background in finance and business development.
Patrick Perry received their Bachelor of Arts degree in History from Yale University in 1989. Patrick later pursued a Master of Business Administration degree in Finance at The Wharton School, which they completed in 1997.
This person is not in any teams
DVLP Medicines
DVLP Medicines is building a new infrastructure for drug development on the blockchain. By digitizing drug assets, financing, and development workflows, we are reimagining and accelerating the entire process to turn more molecules into medicines.